Drug Patents owned by Spil

1. List of Aspruzyo Sprinkle drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10898444 SPIL Extended release multiparticulates of ranolazine
Jan, 2038

(14 years from now)

US11510878 SPIL NA
Jan, 2038

(14 years from now)

Drugs and Companies using RANOLAZINE ingredient

Market Authorisation Date: 28 February, 2022

Treatment: NA

Dosage: GRANULES, EXTENDED RELEASE;ORAL

More Information on Dosage

2. List of Kapspargo Sprinkle drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9700530 SPIL Capsule dosage form of metoprolol succinate
Jul, 2035

(12 years from now)

US9504655 SPIL Capsule dosage form of metoprolol succinate
Jul, 2035

(12 years from now)

Drugs and Companies using METOPROLOL SUCCINATE ingredient

Market Authorisation Date: 26 January, 2018

Treatment: NA

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in